Results 151 to 160 of about 24,384 (198)

Roles of immunoglobulin GM and KM allotypes and Fcγ receptor 2 A genotypes in humoral immunity to a conserved microbial polysaccharide in pulmonary diseases. [PDF]

Genes Immun
Pandey JP, Nietert PJ, Namboodiri AM, Kimball C, Flume PA.   +4 more
europepmc   +1 more source

Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis. [PDF]

RMD Open
Andreeva I, Kolb P, Rodon L, Blank N, Lorenz HM, Merkt W.   +5 more
europepmc   +1 more source

Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera. [PDF]

J Clin Microbiol, 2022
Deschermeier C, Ehmen C, von Possel R, Murawski C, Rushton B, Amuasi J, Sarpong N, Maiga-Ascofaré O, Rakotozandrindrainy R, Asogun D, Ighodalo Y, Oestereich L, Duraffour S, Pahlmann M, Emmerich P.   +14 more
europepmc   +1 more source

Identification of miRNAs that target Fcγ receptor-mediated phagocytosis during macrophage activation syndrome. [PDF]

Front Immunol
Varsha KK, Yang X, Cannon AS, Zhong Y, Nagarkatti M, Nagarkatti P.   +5 more
europepmc   +1 more source

VAMP5 promotes Fcγ receptor-mediated phagocytosis and regulates phagosome maturation in macrophages. [PDF]

Mol Biol Cell
Sakurai C, Yamashita N, Azuma K, Hatsuzawa K.   +3 more
europepmc   +1 more source

Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma. [PDF]

J Immunother Cancer
Ku KB, Kim CW, Kim Y, Kang BH, La J, Kang I, Park WH, Ahn S, Lee SK, Lee HK.   +9 more
europepmc   +1 more source

NOD2 activation enhances macrophage Fcγ receptor function and may increase the efficacy of antibody therapy. [PDF]

Front Immunol
Merchand-Reyes G, Bull MF, Santhanam R, Valencia-Pena ML, Murugesan RA, Chordia A, Mo XM, Robledo-Avila FH, Ruiz-Rosado JD, Carson WE, Byrd JC, Woyach JA, Tridandapani S, Butchar JP.   +13 more
europepmc   +1 more source

Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy. [PDF]

Antibodies (Basel)
Beckmann K, Reitinger C, Yan X, Carle A, Blümle E, Jurkschat N, Paulmann C, Prassl S, Kazandjian LV, Loré K, Nimmerjahn F, Fischer S.   +11 more
europepmc   +1 more source

Novel therapeutic agents in clinical development for systemic lupus erythematosus [PDF]

, 2013

core   +1 more source

Site-Specific Glycosylation Analysis of Human and Murine Fcγ Receptor II Family Members Reveals Variant-Specific <i>N</i>-Glycosylation. [PDF]

J Proteome Res
Abdoollah Z, Marrero Roche DE, Pavan CH, Moore E, Chandler KB.   +4 more
europepmc   +1 more source